Alpha 2.0
Login Register
» Authors » Jonathan Behar

Jonathan Behar

Explore the profile of Jonathan Behar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 210
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Public Health
Pharmacology
Top 10 Co-Authors
Simon Claridge
Tom Jackson
Reza Razavi
Manav Sohal
Christopher A Rinaldi
Eva Sammut
Gerald Carr-White
Zhong Chen
Christopher Aldo Rinaldi
Jessica Webb
Published In
Heart Rhythm
Heart Rhythm O2
Eur J Heart Fail
JACC Cardiovasc Interv
Int J Cardiol
Affiliations
Soon will be listed here.
Recent Articles
1.
An anthropomorphic phantom for atrial transseptal puncture simulation training
Zeidan A, Xu Z, Leung L, Byrne C, Sabu S, Zhou Y, et al.
3D Print Med . 2024 Oct; 10(1):34. PMID: 39472399
Background: Transseptal puncture (TSP) is a critical prerequisite for left-sided cardiac interventions, such as atrial fibrillation (AF) ablation and left atrial appendage closure. Despite its routine nature, TSP can be...
2.
Predictors of the efficacy of His bundle pacing in patients with a prolonged PR interval: A stratified analysis of the HOPE-HF randomized controlled trial
Keene D, Kaza N, Srinivasan D, Ali N, Tanner M, Foley P, et al.
Eur J Heart Fail . 2024 Jul; 26(10):2261-2268. PMID: 39023285
Aims: The randomized, double-blind, placebo-controlled HOPE-HF trial assessed the benefit of atrio-ventricular (AV) delay optimization delivered using His bundle pacing. It recruited patients with left ventricular ejection fraction ≤40%, PR...
3.
The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use
MacLean E, Mahtani K, Honarbakhsh S, Butcher C, Ahluwalia N, Dennis A, et al.
Circ Arrhythm Electrophysiol . 2024 Jan; 17(3):e012446. PMID: 38258308
Background: Antimicrobial envelopes reduce the incidence of cardiac implantable electronic device infections, but their cost restricts routine use in the United Kingdom. Risk scoring could help to identify which patients...
4.
Single-center experience of temporary-permanent pacemaker use in COVID-19 patients supported with veno-venous ECMO: A case series
Frederiks P, Bianchi P, Hunnybun D, Behar J, Garfield B, Ledot S
Perfusion . 2022 Dec; 39(2):382-390. PMID: 36476240
Introduction: In the first year of the COVID-19 pandemic, nine out of 129 patients (7%) developed life-threatening bradycardia episodes ultimately requiring a TPPM, whilst being supported with VV-ECMO for severe...
5.
Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial
Whinnett Z, Shun-Shin M, Tanner M, Foley P, Chandrasekaran B, Moore P, et al.
Eur J Heart Fail . 2022 Nov; 25(2):274-283. PMID: 36404397
Aims: Excessive prolongation of PR interval impairs coupling of atrio-ventricular (AV) contraction, which reduces left ventricular pre-load and stroke volume, and worsens symptoms. His bundle pacing allows AV delay shortening...
6.
A multicenter prospective randomized controlled trial of cardiac resynchronization therapy guided by invasive dP/dt
Sohal M, Hamid S, Perego G, Della Bella P, Adhya S, Paisey J, et al.
Heart Rhythm O2 . 2021 Jun; 2(1):19-27. PMID: 34113901
Background: No periprocedural metric has demonstrated improved cardiac resynchronization therapy (CRT) outcomes in a multicenter setting. Objective: We sought to determine if left ventricular (LV) lead placement targeted to the...
7.
Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapy
Jackson T, Claridge S, Behar J, Yao C, Elliott M, Mehta V, et al.
Heart Rhythm O2 . 2021 Jun; 2(1):12-18. PMID: 34113900
Background: Cardiac resynchronization therapy (CRT) produces acute changes in electric resynchronization that can be measured noninvasively with electrocardiographic body surface mapping (ECGi). The relation between baseline acute electrophysiology metrics and...
8.
Pacemaker-mediated tachycardia in a dual-lead CRT-D: What is the mechanism?
Monkhouse C, Cambridge A, Chow A, Behar J
Pacing Clin Electrophysiol . 2020 Oct; 44(1):151-155. PMID: 33058215
A 73-year-old gentleman with dilated cardiomyopathy, left bundle branch block and a left ventricular (LV) ejection fraction of 20% was implanted with two LV leads in a tri-ventricular cardiac resynchronisation...
9.
Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system
Sieniewicz B, Betts T, James S, Turley A, Butter C, Seifert M, et al.
Heart Rhythm . 2020 Mar; 17(8):1291-1297. PMID: 32165181
Background: Biventricular endocardial pacing (BiV ENDO) is a therapy for heart failure patients who cannot receive transvenous epicardial cardiac resynchronization therapy (CRT) or have not responded adequately to CRT. BiV...
10.
Autonomic Modulation in Patients with Heart Failure Increases Beat-to-Beat Variability of Ventricular Action Potential Duration
Porter B, Bishop M, Claridge S, Behar J, Sieniewicz B, Webb J, et al.
Front Physiol . 2017 Jun; 8:328. PMID: 28611676
Exaggerated beat-to-beat variability of ventricular action potential duration (APD) is linked to arrhythmogenesis. Sympathetic stimulation has been shown to increase QT interval variability, but its effect on ventricular APD in...